Parenterally administered vancomycin in 29 dogs and 7 cats (2003‐2017)
Background Vancomycin is commonly used to treat resistant bacterial infections in people. Reported adverse effects of vancomycin in people include acute kidney injury (AKI), neutropenia, and systemic allergic reaction. Given the increased incidence of vancomycin‐resistant bacterial infections in peo...
Main Authors: | Ian M. DeStefano, Annie S. Wayne, Elizabeth A. Rozanski, Jonathan M. Babyak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Journal of Veterinary Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1111/jvim.15357 |
Similar Items
-
Chemotranscriptomic Profiling Defines Drug-Specific Signatures of the Glycopeptide Antibiotics Dalbavancin, Vancomycin and Chlorobiphenyl-Vancomycin in a VanB-Type-Resistant Streptomycete
by: Andy Hesketh, et al.
Published: (2021-02-01) -
The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study
by: Cornelius Remschmidt, et al.
Published: (2017-09-01) -
Factors associated with Clostridium difficile diarrhea in a hospital in Beijing, China
by: Z. Lv, et al.
Published: (2014-12-01) -
Involving Ornithologists in the Surveillance of Vancomycin-Resistant Enterococci
by: M. Sellin, et al.
Published: (2000-02-01) -
Use of Local Antibiogram Data and Antimicrobial Importance Ratings to Select Optimal Empirical Therapies for Urinary Tract Infections in Dogs and Cats
by: Ri Scarborough, et al.
Published: (2020-12-01)